Longitudinal brain structural changes in preclinical Alzheimer's disease
Authors:
- Jordi PeguerolesJPJordi Pegueroles
- Eduard VilaplanaEVEduard Vilaplana
- Daniel AlcoleaDADaniel Alcolea
- Maria Carmona‐IraguiMCMaria Carmona‐Iragui
- Juan ForteaJFJuan Fortea
- Alzheimer'S Disease Neuroimaging InitiativeAIAlzheimer'S Disease Neuroimaging Initiative
- 28 September 2016
- journal article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 13 (5) , 499-509
Abstract
Introduction: Brain structural changes in preclinical Alzheimer's disease (AD) are poorly understood.Methods: We compared the changes in cortical thickness in the ADNI cohort during a 2‐year follow‐up between the NIA‐AA preclinical AD stages defined by cerebrospinal fluid (CSF) biomarker levels. We also analyzed the correlation between baseline CSF biomarkers and cortical atrophy rates.Results: At follow‐up, stage 1 subjects showed reduced atrophy rates in medial frontal areas and precuneus compared to stage 0 subjects, whereas stage 2/3 subjects presented accelerated atrophy in medial temporal structures. Low CSF Aβ1–42 levels were associated with reduced atrophy rates in subjects with normal tau levels and high CSF tau levels with accelerated atrophy only in subjects with low Aβ1–42 levels.Discussion: Our longitudinal data confirm a biphasic trajectory of changes in brain structure in preclinical AD. These have implications in AD trials, both in patient selection and the use of MRI as a surrogate marker of efficacy.Keywords
Funding Information
- European Regional Development Fund
- Alzheimer's Disease Neuroimaging Initiative
- National Institutes of Health (U01 AG024904)
- U.S. Department of War (W81XWH‐12‐2‐0012)
- National Institute on Aging
- National Institute of Biomedical Imaging and Bioengineering
This publication has 49 references indexed in Scilit:
- Amyloid burden, cortical thickness, and cognitive function in the Wisconsin Registry for Alzheimer's PreventionAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2015
- Cerebrospinal fluid β‐amyloid and phospho‐tau biomarker interactions affecting brain structure in preclinical Alzheimer diseaseAnnals of Neurology, 2014
- Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- Amyloid‐β associated cortical thinning in clinically normal elderlyAnnals of Neurology, 2010
- Larger temporal volume in elderly with high versus low beta-amyloid depositionBrain, 2010
- Brain Atrophy in Healthy Aging Is Related to CSF Levels of Aβ1-42Cerebral Cortex, 2010
- Decreased cerebrospinal fluid Aβ42 correlates with brain atrophy in cognitively normal elderlyAnnals of Neurology, 2009
- Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjectsBrain, 2008
- The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive IndividualsCerebral Cortex, 2008
- β‐amyloid burden is not associated with rates of brain atrophyAnnals of Neurology, 2008